Wake Forest University Health Sciences — Winston-Salem, North Carolina

Public research footprint of Wake Forest University Health Sciences, compiled from the ClinicalTrials.gov public registry.

1,087

Registered studies

367

Active

153

Recruiting now

586

Completed

112

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Lung Non-Squamous Non-Small Cell Carcinoma

Recently updated registry entries

NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT05600894 — Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Wake Forest University Health Sciences?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.